Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans

Jean Soon Park, Jong Hee Chyun, Yoo Kyung Kim, Larry L Line, Boon P Chew, Jean Soon Park, Jong Hee Chyun, Yoo Kyung Kim, Larry L Line, Boon P Chew

Abstract

Background: Astaxanthin modulates immune response, inhibits cancer cell growth, reduces bacterial load and gastric inflammation, and protects against UVA-induced oxidative stress in in vitro and rodent models. Similar clinical studies in humans are unavailable. Our objective is to study the action of dietary astaxanthin in modulating immune response, oxidative status and inflammation in young healthy adult female human subjects.

Methods: Participants (averaged 21.5 yr) received 0, 2, or 8 mg astaxanthin (n = 14/diet) daily for 8 wk in a randomized double-blind, placebo-controlled study. Immune response was assessed on wk 0, 4 and 8, and tuberculin test performed on wk 8.

Results: Plasma astaxanthin increased (P < 0.01) dose-dependently after 4 or 8 wk of supplementation. Astaxanthin decreased a DNA damage biomarker after 4 wk but did not affect lipid peroxidation. Plasma C-reactive protein concentration was lower (P < 0.05) on wk 8 in subjects given 2 mg astaxanthin. Dietary astaxanthin stimulated mitogen-induced lymphoproliferation, increased natural killer cell cytotoxic activity, and increased total T and B cell subpopulations, but did not influence populations of Thelper, Tcytotoxic or natural killer cells. A higher percentage of leukocytes expressed the LFA-1 marker in subjects given 2 mg astaxanthin on wk 8. Subjects fed 2 mg astaxanthin had a higher tuberculin response than unsupplemented subjects. There was no difference in TNF and IL-2 concentrations, but plasma IFN-gamma and IL-6 increased on wk 8 in subjects given 8 mg astaxanthin.

Conclusion: Therefore, dietary astaxanthin decreases a DNA damage biomarker and acute phase protein, and enhances immune response in young healthy females.

Figures

Figure 1
Figure 1
Concentrations of plasma astaxanthin in human subjects fed 0, 2 or 8 mg astaxanthin daily for 8 wk. a, b Different letters represent significant treatment differences (P < 0.05) as analyzed by protected LSD test. Values are means; variation is expressed as a representative overall standard error.
Figure 2
Figure 2
Lymphocyte proliferation induced with phytohemagglutinin, concanavalin A and pokeweed mitogen in human subjects fed 0, 2 or 8 mg astaxanthin daily for 8 wk. Responses to high concentrations of mitogens (10 mg phytohemmaglutinin/L, 10 mg concanavalin A/L and 5 mg pokeweed mitogen/L final concentration) are shown. a, b Different letters represent significant treatment differences (P < 0.05) as analyzed by protected LSD test. Values are means ± SEM.
Figure 3
Figure 3
Delayed-type hypersensitivity tuberculin test in human subjects fed 0, 2 or 8 mg astaxanthin daily for 8 wk. a, b Different letters represent significant treatment differences (P < 0.05) as analyzed by protected LSD test. Values are means ± overall standard error.
Figure 4
Figure 4
Plasma concentrations of plasma C-reactive protein in human subjects fed 0, 2 or 8 mg astaxanthin daily for 8 wk. a, b Different letters represent significant treatment differences (P < 0.05) as analyzed by protected LSD test. Values are means ± overall standard error.
Figure 5
Figure 5
Concentrations of plasma 8-hydroxy-2'-deoxyguanosine in human subjects fed 0, 2 or 8 mg astaxanthin daily for 8 wk. a, b Different letters represent significant treatment differences (P < 0.05) as analyzed by protected LSD test. Values are means ± overall standard error (OSE = Root MSE÷square root of n+1).

References

    1. Chew BP, Park JS. In: Carotenoids: Nutrition and Health. Britton G, Liaanen-Jensen S, Pfander H, editor. Vol. 5. Birkhauser Press; 2009. Carotenoids Against Disease: Part C: The Immune System and Disease; pp. 363–82. full_text.
    1. Park JS, Chew BP, Wong TS. Dietary lutein from marigold extract inhibits mammary tumor development in BALB/c mice. J Nutr. 1998;128:1650–1656.
    1. Kurashige M, Okimasu E, Inoue M, Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR. 1990;22:27–38.
    1. Chew BP, Wong MW, Park JS, Wong TS. Dietary β-carotene and astaxanthin but not canthaxanthin stimulate splenocyte function in mice. Anticancer Re. 1999;19:5223–5227.
    1. Bennedsen M, Wang X, Willen R, Wadstrom T, Andersen LP. Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol Lett. 1999;70:185–189. doi: 10.1016/S0165-2478(99)00145-5.
    1. Jyonouchi H, Zhang L, Gross M, Tomita Y. Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr Cancer. 1994;21:47–58. doi: 10.1080/01635589409514303.
    1. Chew BP, Park JS, Wong MW, Wong TS. A comparison of the anticancer activities of dietary β-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res. 1999;19:1849–1853.
    1. O'Connor I, O'Brien NM. Modulation of UVA light-induced oxidative stress by β-carotene, lutein and astaxanthin in cultured fibroblasts. J Dermatol Sci. 1998;16:226–230. doi: 10.1016/S0923-1811(97)00058-3.
    1. Park JS, Chew BP, Wong TS. Dietary lutein absorption from marigold extract is rapid in Balb/c mice. J Nutr. 1998;128:1802–6.
    1. Chew BP, Park JS, Wong TS, Kim HW, Weng BB, Byrne KM, Hayek MG, Reinhart GA. Dietary β-carotene stimulates cell-mediated and humoral immune response in dogs. J Nutr. 2000;130:1910–1913.
    1. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA. Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr. 2007;83:1118–1125.
    1. SAS. SAS/STAT User's Guide. SAS Institute Inc., Cary, NC; 1991.
    1. Chew BP, Park JS, Hayek MG, Massimino S, Reinhart GA. Cell-mediated and humoral immune response in dogs fed astaxanthin. FASEB J. 2004;18:A533.
    1. Park JS, Chew BP, Hayek MG, Massimino S, Reinhart GA. Dietary β-carotene enhances cell-mediated and humoral immune response in cats. FASEB J. 2004;18:A53.
    1. Okai Y, Higashi-Okai K. Possible immunomodulating activities of carotenoids in in vitro cell culture experiments. Int J Immunopharmacol. 1996;18:753–758. doi: 10.1016/S0192-0561(97)85558-0.
    1. Jyonouchi H, Sun S, Iijima K, Gross MD. Antitumor activity of astaxanthin and its mode of action. Nutr Cancer. 2000;36:59–65. doi: 10.1207/S15327914NC3601_9.
    1. Kurihara H, Koda H, Asami S, Kiso Y, Tanaka T. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci. 2002;70:2509–2520. doi: 10.1016/S0024-3205(02)01522-9.
    1. Cerveny CG, Chew BP, Park JS, Wong TS. Dietary lutein inhibits tumor growth and normalizes lymphocyte subsets in tumor-bearing mice. FASEB J. 1999;13:A210.
    1. Jyonouchi H, Zhang L, Tomita Y. Studies of immunomodulating actions of carotenoids II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation. Nutr Cancer. 1993;19:269–280. doi: 10.1080/01635589309514258.
    1. Jyonouchi H, Sun S, Tomita Y, Gross MD. Astaxanthin, a carotenoid without vitamin A activity, augments antibody responses in cultures including T-helper cell clones and suboptimal doses of antigen. J Nutr. 1995;125:2483–2492.
    1. Kim HW, Chew BP, Wong TS, Park JS, Weng BB, Byrne KM, Hayek MG, Reinhart GA. Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopathol. 2000;74:315–327. doi: 10.1016/S0165-2427(00)00180-X.
    1. Kim HW, Chew BP, Wong TS, Park JS, Weng BB, Byrne KM, Hayek MG, Reinhart GA. Modulation of humoral and cell-mediated immune responses by dietary lutein in cats. Vet Immunol Immunopathol. 2000;73:331–41. doi: 10.1016/S0165-2427(00)00152-5.
    1. Bejma J, Ji LL. Aging and acute exercise enhance free radical generation in rat skeletal muscle. J Appl Physiol. 1999;87:465–470.
    1. Ji LL. Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med. 1999;222:283–292. doi: 10.1046/j.1525-1373.1999.d01-145.x.
    1. Gershon D. The mitochondrial theory of aging: is the culprit a faulty disposal system rather than indigenous mitochondrial alterations? Exp Gerontol. 1999;34:613–619. doi: 10.1016/S0531-5565(99)00010-8.
    1. Aoi W, Naito Y, Sakuma K, Kuchide M, Tokuda H, Maoka T, Toyokuni S, Oka S, Yasuhara M, Yoshikawa T. Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid Redox Signal. 2003;5:139–144. doi: 10.1089/152308603321223630.
    1. Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Opthalmol Vis Sci. 2003;44:2694–2701. doi: 10.1167/iovs.02-0822.
    1. Lee SJ, Bai SK, Lee KS, Namkoong S, Na HJ, Ha KS, Han JA, Yim SV, Chang K, Kwon YG, Lee SK, Kim YM. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NFκB activation. Mol Cells. 2003;16:97–105.
    1. Barros MP, Pinto E, Colepicolo P, Pedersen M. Astaxanthin and peridinin inhibit oxidative damage in (Fe2+)-loaded liposomes: scavenging oxyradicals or changing membrane permeability? Biochem Biophys Res Commun. 2001;288:225–232. doi: 10.1006/bbrc.2001.5765.
    1. Iwamoto T, Hosoda K, Hirano R, Kurata H, Matsumoto A, Miki W, Kamiyama M, Itakura H, Yamamoto S, Kondo K. Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb. 2000;7:216–222.
    1. Palozza P, Krinsky N. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch Biochem Biophys. 1992;297:291–295. doi: 10.1016/0003-9861(92)90675-M.
    1. Wisniewska A, Subczynski WK. Effects of polar carotenoids on the shape of the hydrophobic barrier of phospholipids bilayers. Biochim Biophys Acta. 1998;1368:235–246. doi: 10.1016/S0005-2736(97)00182-X.
    1. Tanaka T, Morishita Y, Suzui M, Kojima T, Okumura A, Mori H. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis. 1994;15:15–19. doi: 10.1093/carcin/15.1.15.
    1. Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 1995;55:4059–4064.
    1. Gradelet S, Le Bon AM, Berges R, Suschetet M, Astorg P. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism. Carcinogenesis. 1998;19:403–411. doi: 10.1093/carcin/19.3.403.
    1. Lyons NM, O'Brien NM. Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture. J Dermatol Sci. 2002;30:73–84. doi: 10.1016/S0923-1811(02)00063-4.
    1. Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, Maoka T, Takahashi J, Yoshikawa T. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors. 2004;20:49–59. doi: 10.1002/biof.5520200105.
    1. Barros MP, Pinto E, Colepicolo P, Pedersen M. Astaxanthin and peridinin inhibit oxidative damage in Fe2+-loaded liposomes: scavenging oxyradicals or changing membrane permeability? Biochem Biophy Res Comm. 2001;288:225–32. doi: 10.1006/bbrc.2001.5765.
    1. McNulty HP, Byun J, Lockwood SF, Jacob RF, Mason RP. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochim Biochys Acta. 2007;1768:167–74. doi: 10.1016/j.bbamem.2006.09.010.
    1. Subczynski WK, Hyde LM. Permeability of nitric oxide through lipid bilayer membranes. Free Rad Res. 1996;24:343–49. doi: 10.3109/10715769609088032.
    1. Osterlie M, Bjerkeng B, Liaaen-Jensen S. Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J Nutr Biochem. 2000;11:482–490. doi: 10.1016/S0955-2863(00)00104-2.
    1. Torissen OJ, Hardy RW, Shearer K. Pigmentation of salmonids - carotenoid deposition and metabolism. CRC Critical reviews in Aquatic Sciences. 1989;1:209–225.
    1. Turujman SA, Wamer WG, Wei RR, Albert RH. Rapid liquid chromatographic method to distinguish wild salmon from aquacultured salmon fed synthetic astaxanthin. J AOAC Int. 1997;80:622–632.
    1. Spiller GA, Dewell A. Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial. J Med Food. 2003;6:51–6. doi: 10.1089/109662003765184741.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj